Inhibrx Biosciences (INBX) Times Interest Earned (2023 - 2025)

Inhibrx Biosciences (INBX) reported Times Interest Earned of -$9.71 for Q4 2025, up 8.66% quarter-over-quarter from -$10.63 in Q3 2025.

Inhibrx Biosciences (INBX) Times Interest Earned (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of Times Interest Earned data on file, last reported at -$9.71 in Q4 2025.

Times Interest Earned for Q4 2025 came in at -$9.71, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$11.07 (up 54.94% YoY), and the FY2025 annual result was -$11.07, up 54.94% from the prior year.
Times Interest Earned improved to -$9.71 in Q4 2025 per INBX's latest filing, from -$10.63 in the prior quarter.
Over five years, Times Interest Earned peaked at -$5.23 in Q2 2023 and troughed at -$30.01 in Q2 2024.
A 3-year average of -$11.74 and a median of -$9.71 in 2025 frame the typical range for Times Interest Earned.
The sharpest annual moves came in 2024 and 2025: Times Interest Earned slumped 473.91% in 2024, then jumped 70.95% in 2025.
A 3-year view of Times Interest Earned shows it stood at -$10.74 in 2023, then tumbled by 179.53% to -$30.01 in 2024, then soared by 67.65% to -$9.71 in 2025.
Business Quant data shows INBX's Times Interest Earned at -$9.71 in Q4 2025, -$10.63 in Q3 2025, and -$8.72 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Inhibrx Biosciences	186.16 Mn	186.16 Mn	-	-9.71

Download Data